July 14,2006

Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs

Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.

Next Article Previous Article

Recent News

09/25/20 Grassley, Colleagues Introduce Bill to Increase Health Care Access for Children
09/24/20 Grassley Corrects Record on Dem Social Security Misinformation, Again
09/23/20 Grassley Statement on New SEC Whistleblower Rules
09/23/20 Finance Committee Releases Report on Performance of Nursing Homes & Long-Term Care Facilities During the COVID-19 Pandemic
09/23/20 ICYMI: IRS Data: Middle Class Americans Saw Biggest Tax Reduction from Trump Tax Cuts